Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g ...
These data do not support an increased risk for adverse outcomes associated with concomitant ceftriaxone and calcium infusions in adult critically ill patients; however, our study was limited by low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback